I think it’s time for me to send out an update on the new ultra-rapid acting insulins but before I jump into what’s new, let me back up a minute and talk about what’s “old”. Most of us use a rapid-acting insulin of some kind- mostly either Humalog or NovoLog. But we all know that these insulins ar
Steve and I had the pleasure of going to Vienna, Austria together two weeks ago for the diabetes technology meeting, and while there definitely was some cool stuff presented in the artificial pancreas world, my update comes from my own AP world. As I've mentioned before, I started on LOOP about 4
Nearly 50 years after the autoimmune nature of type 1 diabetes was discovered, no therapy has been approved to alter the course of the disease at any stage. However, during that same period, technology has been delivering tools to help patients achieve better glycemic control and reduce the burden o
Two type 1 endocrinologists review the pros and cons of the latest CGMs to hit the market – Abbott’s Freestyle Libre and Senseonics’ Eversense.
We all have them…mistakes we’ve made that we don’t even want to share with our own mother. Dr. Jeremy Pettus puts it all out there and gets real about what recently happened when he took the right dose of the wrong insulin.
Did you know CGMs come out of the box with their repeat low alerts set to “off”?
CGM’s are life-changing and life-saving. Learn how to make the most of yours, and use those bells and whistles to your advantage!